The pandemic has accelerated the development of mRNA vaccines, which could have significant implications for cancer research, said Danny Milner, chief medical officer of the American Society for Clinical Pathology, and adjunct associate professor of immunology and infectious diseases in the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health.
In mid-October, First Lady Dr. Jill Biden asked to visit the Hollings Cancer Center at the Medical University of South Carolina to help raise awareness of the need for breast cancer screening, education, and treatment—particularly among underserved minority women.
Stanley Reimann was just one man, but in September 1930 he faced the daunting task of sustaining a fledgling research institute, which had started in 1921 in a makeshift lab above a hospital morgue, dedicated to unraveling the causes of cancer.
Researchers have made tremendous progress in cancer prevention and treatment over the past few decades. As a result, the death rates for many common cancers are declining in the U.S.1 Unfortunately, not everyone is benefitting from these breakthroughs.
The Cancer Prevention and Research Institute of Texas will focus on finding solutions for health disparities among patients with cancer, Michelle Le Beau, the institute’s new chief scientific officer, said to The Cancer Letter.
David Morse Livingston, a Dana-Farber Cancer Institute scientist who made key discoveries and forged novel collaborations that opened new paths in cancer science, died suddenly Oct. 17. Livingston was 80.
The National Academy of Medicine announced the election of 90 regular members and 10 international members.
When Susan Love joked that a group of breast cancer advocates in Salt Lake City should march topless to George H. W. Bush’s White House, she didn’t expect to be taken seriously.
Breast cancer awareness month edition, with 1994 letters to the editor on mammography and the Bernard Fisher scandal.
In the field of radiation oncology there is currently tremendous excitement about the delivery of radiation at much higher dose rates than typically used clinically.
